Company news

Chimeric Therapeutics Limited news in 2026

Chimeric Therapeutics Limited's news releases, calls and decks from 2026, newest first.

View company

Notification of cessation of securities - CHM

October 30, 2026

Notice of Annual General Meeting/Proxy Form

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Ceasing to be a substantial holder for CHM

October 8, 2026

Notice of initial substantial holder for CHM

October 6, 2026

Final Director's Interest Notice - LR

October 5, 2026

Final Director's Interest Notice - BG

October 5, 2026

Initial Director's Interest Notice - RM

October 5, 2026

FY2026 Annual Report, creditor update and Board changes

September 30, 2026

Application for quotation of securities - CHM

September 29, 2026

Application for quotation of securities - CHM

September 21, 2026

Application for quotation of securities - CHM

September 3, 2026

Appendix 4E and Preliminary Final Report

August 31, 2026

Application for quotation of securities - CHM

August 27, 2026

Application for quotation of securities - CHM

August 20, 2026

CHM ceases enrolment in Phase 1 trial and Company update

August 18, 2026

Trading Halt

August 16, 2026

Application for quotation of securities - CHM

August 6, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

July 31, 2026

Chimeric receives $1.62M advance on FY26 R&D tax incentive

July 29, 2026

Investor Presentation

July 27, 2026

CHM CDH17 Phase 1 clinical trial update - New DL 3 data

July 15, 2026

Appointment of Financial Adviser for Strategic Review

June 30, 2026

CHM announces positive Phase 1/2 data at ASCO

May 31, 2026

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

April 21, 2026

Consolidation/Split - CHM

March 18, 2026

Chimeric receives $1.8 M advance on FY26 R&D tax incentive

March 1, 2026

Half Year Report and Appendix 4D 31 December 2025

February 27, 2026

Portfolio streamlined - return of CHM CLTX to City of Hope

February 26, 2026

Funding and EGM update

February 24, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 27, 2026

Decks in 2026